Follow The Filings

ENTX Entera Bio

Entera Bio earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by ENTX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ENTX insider trades
  • $141K bought by 5 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Geno J Germano Director
    Buy
    $26K 20,000 shares at $1.30 +100% to stake
    Traded Mar 9 Filed Mar 11
  2. Sean Ellis Director
    Buy
    $12K 10,000 shares at $1.23 +5.6% to stake
    Traded Mar 5 Filed Mar 9
  3. Steven D Rubin Director
    Buy
    $7,450 5,000 shares at $1.49 +50% to stake
    Traded Feb 12 Filed Feb 17
  4. Haya Taitel Director
    Buy
    $11K 7,500 shares at $1.48
    Traded Feb 10 Filed Feb 11
  5. Geno J Germano Director
    Buy
    $30K 20,000 shares at $1.49
    Traded Feb 10 Filed Feb 11
  6. Steven D Rubin Director
    Buy
    $12K 10,000 shares at $1.20 New stake
    Traded Feb 9 Filed Feb 11
  7. Sean Ellis Director
    Buy
    $22K 18,000 shares at $1.24 +11% to stake
    Traded Feb 9 Filed Feb 11
  8. Miranda Jayne Toledano CEO
    Buy
    $20K 11,000 shares at $1.81 +2.6% to stake
    Traded Dec 29, 2025 Filed Dec 30, 2025

Also filed in the last 12 months, not counted as buying or selling: 15 stock grants.

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
DEF 14A
8-K 5.02,7.01,9.01
424B3
8-K 7.01,8.01,9.01
8-K 2.02,7.01,9.01
10-Q
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13D —
SCHEDULE 13G —
SCHEDULE 13G —
8-K 1.01,3.02,5.02,9.01
8-K 5.02,5.03,5.07,9.01
DEF 14A
DEFA14A
424B3
8-K 2.02,7.01,9.01
10-Q
8-K 1.01,3.02,9.01
8-K 2.02,7.01,9.01
10-K
8-K 7.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.